PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 46 filers reported holding PROQR THRAPEUTICS N V in Q2 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,931,000 | -25.1% | 2,281,966 | -5.0% | 1.16% | -60.7% |
| Q2 2020 | $14,602,000 | +10.7% | 2,401,570 | 0.0% | 2.94% | -42.7% |
| Q1 2020 | $13,185,000 | -30.8% | 2,401,570 | +24.9% | 5.14% | -28.2% |
| Q4 2019 | $19,053,000 | +297.8% | 1,922,570 | +131.2% | 7.16% | +112.2% |
| Q3 2019 | $4,790,000 | -29.7% | 831,661 | +11.1% | 3.37% | +42.6% |
| Q2 2019 | $6,815,000 | – | 748,861 | – | 2.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |